Boryung Pharmaceutical's 'Kanarb' recorded a total of 115.5 billion won sales from its release date
Boryung Pharmaceutical's 'Kanarb' recorded a total of 115.5 billion won sales from its release date of March 1, 2011, to three years after the release of this year.
The profit structure of Kanarb can be divided into three types, such as ▲ domestic sales ▲ overseas sales ▲ others.
First, Kanarb ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.